» Articles » PMID: 30060206

Incidence of New-onset Diabetes Mellitus and Association with Mortality in Childhood Solid Organ Transplant Recipients: a Population-based Study

Abstract

Background: Precise estimates of the long-term risk of new-onset diabetes and its impact on mortality among transplanted children are not known.

Methods: We conducted a cohort study comparing children undergoing solid organ (kidney, heart, liver, lung and multiple organ) transplant (n = 1020) between 1991 and 2014 with healthy non-transplanted children (n = 7 134 067) using Ontario health administrative data. Outcomes included incidence of diabetes among transplanted and non-transplanted children, the relative hazard of diabetes among solid organ transplant recipients, overall and at specific intervals posttransplant, and mortality among diabetic transplant recipients.

Results: During 56 019 824 person-years of follow-up, the incidence rate of diabetes was 17.8 [95% confidence interval (CI) 15-21] and 2.5 (95% CI 2.5-2.5) per 1000 person-years among transplanted and non-transplanted children, respectively. The transplant cohort had a 9-fold [hazard ratio (HR) 8.9; 95% CI 7.5-10.5] higher hazard of diabetes compared with those not transplanted. Risk was highest within the first year after transplant (HR 20.7; 95% CI 15.9-27.1), and remained elevated even at 5 and 10 years of follow-up. Lung and multiple organ recipients had a 5-fold (HR 5.4; 95% CI 3.0-9.8) higher hazard of developing diabetes compared with kidney transplant recipients. Transplant recipients with diabetes had a three times higher hazard of death compared with those who did not develop diabetes (HR 3.3; 95% CI 2.3-4.8).

Conclusions: The elevated risk of diabetes in transplant recipients persists even after a decade, highlighting the importance of ongoing surveillance. Diabetes after transplantation increases the risk of mortality among childhood transplant recipients.

Citing Articles

"Effect of post-kidney transplant diabetes mellitus on long-term outcomes in a cohort of pediatric kidney transplant recipients from 2005 to 2022." Survival analysis.

Calvo-Herrera M, Serna-Campuzano A, Isaza-Lopez M, Villegas-Arbelaez E, Rojas-Rosas L, Serna-Higuita L BMJ Paediatr Open. 2024; 8(1).

PMID: 39725454 PMC: 11683984. DOI: 10.1136/bmjpo-2024-002710.


LASSO-derived nomogram predicting new-onset diabetes mellitus in patients with kidney disease receiving immunosuppressive drugs.

Shao L, Luo C, Yuan C, Ye X, Zeng Y, Ren Y J Clin Pharm Ther. 2022; 47(10):1627-1635.

PMID: 35791031 PMC: 9796007. DOI: 10.1111/jcpt.13713.

References
1.
Hathout E, Alonso E, Anand R, Martz K, Imseis E, Johnston J . Post-transplant diabetes mellitus in pediatric liver transplantation. Pediatr Transplant. 2008; 13(5):599-605. DOI: 10.1111/j.1399-3046.2007.00603.x. View

2.
Chanchlani R, Kim S, Kim E, Banh T, Borges K, Vasilevska-Ristovska J . Incidence of hyperglycemia and diabetes and association with electrolyte abnormalities in pediatric solid organ transplant recipients. Nephrol Dial Transplant. 2017; 32(9):1579-1586. PMC: 5837606. DOI: 10.1093/ndt/gfx205. View

3.
Garg A, Pouget J, Young A, Huang A, Boudville N, Hodsman A . Fracture risk in living kidney donors: a matched cohort study. Am J Kidney Dis. 2012; 59(6):770-6. DOI: 10.1053/j.ajkd.2012.01.013. View

4.
Wagner K, Webber S, Kurland G, Boyle G, Miller S, Cipriani L . New-onset diabetes mellitus in pediatric thoracic organ recipients receiving tacrolimus-based immunosuppression. J Heart Lung Transplant. 1997; 16(3):275-82. View

5.
Pham P, Pham P, V Pham S, Pham P, Pham P . New onset diabetes after transplantation (NODAT): an overview. Diabetes Metab Syndr Obes. 2011; 4:175-86. PMC: 3131798. DOI: 10.2147/DMSO.S19027. View